Chronic Disease Management Act of 2020

Bill: 116-s-3200
Sponsor: full_name: Sen. Thune, John [R-SD]
Introduced: 2020-01-15
Policy area: Taxation
Subjects: Health care costs and insurance

Health care coverage and access

Health promotion and preventive care

Income tax deductions
Latest action: action_date: 2020-01-15
text: Read twice and referred to the Committee on Finance. (text: CR S248)

Summaries:
action_date: 2020-01-15
action_desc: Introduced in Senate
text: <p><b>Chronic Disease Management Act of 2020</b></p> <p> This bill modifies requirements for health savings accounts (HSAs) to permit the high deductible health plans required for an HSA to provide care for chronic conditions with no deductible. The bill covers any service or item used to treat a chronic condition if (1) such service or item is low-cost, (2) there is medical evidence of the effectiveness of such service or item, and (3) there is a strong likelihood that the use of such service or item will prevent the exacerbation of the chronic condition or the development of a secondary condition that requires significantly higher cost treatment.</p>

tv_txt: II 116th CONGRESS 2d Session S. 3200 IN THE SENATE OF THE UNITED STATES January 15, 2020 Mr. Thune (for himself, Mr. Carper , Mr. Cramer , Ms. Smith , Ms. McSally , and Ms. Sinema ) introduced the following bill; which was read twice and referred to the Committee on Finance A BILL To amend the Internal Revenue Code of 1986 to permit high deductible health plans to provide chronic disease prevention services to plan enrollees prior to satisfying their plan deductible.

1. Short title This Act may be cited as the Chronic Disease Management Act of 2020 . 2. Chronic disease prevention (a) In general Section 223(c)(2) of the Internal Revenue Code of 1986 is amended by redesignating subparagraph (D) as subparagraph (E) and by inserting after subparagraph (C) the following new subparagraph: (D) Preventive care services and items for chronic conditions For purposes of subparagraph (C), preventive care shall include any service or item used to treat an individual with a chronic condition if— (i) such service or item is low-cost, (ii) in regards to such service or item, there is medical evidence supporting high cost efficiency of preventing exacerbation of the chronic condition or the development of a secondary condition, and (iii) there is a strong likelihood, documented by clinical evidence, that with respect to the class of individuals utilizing such service or item, the specific service or use of the item will prevent the exacerbation of the chronic condition or the development of a secondary condition that requires significantly higher cost treatments. . (b) Effective date The amendments made by this section shall apply to coverage for months beginning after the date of the enactment of this Act.